Werner Verbiest

Global Head, Janssen Diagnostics

Luc Truyen, MD, PhD.

Global Head of Development & External Affairs, Neuroscience Therapeutic Area – Janssen R&D, LLC

J.D. Alvarez, M.D., Ph.D.

Vice President, Oncology Diagnostics, for the Janssen Pharmaceutical Companies of Johnson & Johnson

Mariano Alvarez, PhD

Chief Scientific Officer, DarwinHealth™

Ashish Atreja, MD, MPH

Asst. Professor & Chief Innovation Officer, Icahn School of Medicine at Mount Sinai

Dina Avery, DHSc, MA, MAEd

Assistant Professor & Regulatory Affairs Specialist, University of Alabama at Birmingham

John M. Baldoni, PhD

Senior Vice President, In silico Drug Discovery, GSK Pharma R&D

Annette Bakker, Ph.D.

President and Chief Scientific Officer, the Children’s Tumor Foundation

Michele M. Becci, MBA

Vice President, Industry Strategy at Medidata Solutions

Christina Bender, PhD, MBA

Director, Global Diagnostic Pipeline Strategy – Novartis

Carol Berry, MBA

Senior Vice-President and Chief Business Officer, Caprion Biosciences Inc.

Wayne Caldwell

Director – Diaceutics Inc.

Jim Cassidy MD PhD

Corporate VP, Celgene

Gregory J. Downing, D.O., Ph.D.

Founder of Innovation Horizons, LLC

Ysabel Duron

Founder & Director, Latino Cancer Institute

Jim Fackler, M.D.

Associate Professor, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine

Andrea Ferris

President & CEO, LUNGevity Foundation

Ryan Fukushima, MBA

Chief Operating Officer, Tempus

Anita Krithivas Gandhi, Ph.D

Senior Director, Translational Development and Diagnostics Department, Celgene Corporation

Marc Grodman, MD

Co-Founder & CEO, Genosity

Sarah Hersey, MS, MBA, RAC

Head of Precision Medicine and Companion Diagnostics, Celgene Corporation

Jeffrey R. Idle, PhD

Endowed Professor and Director, Arthur G. Zupko’s Systems Pharmacology and Pharmacogenomics, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University

Jay S Kaufman, Ph.D.

Professor, Department of Epidemiology, Biostatistics and Occupational Health, McGill University

Kevin Kalinsky, M.D., M.S

Assistant Professor of Medicine at the NewYork-Presbyterian Hospital/Columbia University Medical Center

Peter Kapitein, PhD

Founder Inspire2Live

Mark G. Kris, MD

Attending Physician, Thoracic Oncology Service, The William and Joy Ruane Chair in Thoracic Oncology, Lead Physician, Memorial Sloan Kettering–IBM Watson Collaboration

Eric B. Kmiec, Ph.D

Founder and Director of the Gene Editing Institute at the Helen F. Graham Cancer Center & Research Institute at Christiana Care Health System

Michael Kolodziej M.D.

Vice President and Chief Innovation Officer, ADVI Health

Andrew Kung, MD, PhD

Pediatric Oncologist, Chair, Department of Pediatrics, MSKCC

Arturo Loaiza-Bonilla, MD MSEd FACP

Chief of Medical Oncology and Medical Director of Research at Cancer Treatment Centers of America – ERMC, and also Co-Founder and Chief Medical Officer at Massive Bio

J Blake Long, MD, MBA

President, Long Health Care Consulting

Hannah Mamuszka

Founder and CEO of Alva10

Jennifer Manly, PhD

Associate Professor of Neuropsychology in Neurology at the Taub Institute for Research in Alzheimer’s Disease and the Aging Brain at Columbia University

Maurie Markman, MD

President of Medicine & Science at Cancer Treatment Centers of America.

Anne-Marie Martin Ph.D.

Senior Vice President and Global Head of Precision Medicine, Novartis

Glenn A. Miller, Ph.D.

Partners Healthcare Innovation’s Market Sector Leader for Radiology, Anesthesiology, Neurology, Neurosurgery and Psychiatry

Robert S. Miller, MD, FACP, FASCO

Vice President and Medical Director, CancerLinQ®

Spyro Mousses, PhD

Executive Scientific Advisor, Medical Intelligence and Innovation Institute Children’s Hospital of Orange County, CEO Systems Oncology

Melanie Nallicheri, MBA

Chief Business Officer and Head, Biopharma, Foundation Medicine

Vaibhav Narayan, PhD, MBA

Vice President of Research IT, Janssen Pharmaceuticals LLC

Melissa J. Nirenberg, MD, PhD

Chief Medical Officer of The New York Stem Cell Foundation

Nate Nussbaum MD

Medical Director, Flatiron Health

Maria Palombini, MBA

Director, Emerging Communities & Initiatives Development, Global Business Strategy & Intelligence, IEEE Standards Association

Samir Parekh, MD

Associate Professor, Icahn School of Medicine at Mount Sinai

Rahul Patel, MS

EVP & GM, Healthcare and Life Sciences, Persistent Systems

Arthur E. Peabody, Jr. JD

Principal of Arthur E. Peabody, Jr., PLLC

Andrew L. Pecora, MD, FACP CPE

President Physician Services Division and Chief Innovations Officer Hackensack Meridian Health, Founder and First President, Regional Cancer Care Associates
Professor of Oncology and Medicine, Georgetown University

Suso Platero, PhD

Head Biomarker Solution Center, Global Leader Precision Medicine, Covance, Inc.

Bob Powell, Pharm.D.

Adjunct Professor, College of pharmacy, University of North Carolina Chapel Hill

Nishadi Rajapakse, Ph.D

Program Director in the Division of Scientific Programs, National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH).

Nicholas Robert, MD.

Medical Director of Health Economic Outcomes Research/Heath Informatics of McKesson Specialty Health.

Owen Roberts

CEO Nobelex Biotech Inc & M4K Pharma

Andrea Sboner, Ph.D.

Senior Director of Informatics and Computational Biology at the Englander Institute for Precision Medicine at Weill Cornell Medicine

Ilona Schelle, PhD

Central Bank of the Netherlands, Patient Advocate at Inspire2Live

Darryle D. Schoepp, Ph.D.

Vice President, Neuroscience Discovery Research, MERCK

Todd Sherer, PhD

Chief Executive Officer of The Michael J. Fox Foundation for Parkinson’s Research

Morten Sogaard, Ph.D

Vice President & Global Head, Target Sciences & Technologies, Pfizer, Inc.

Yauheni Solad, MD, MHS

Medical Director of Digital Health at Yale New Haven Health

Grace E. Terrell , MD MMM

CEO of Envision Genomics

Anjan Thakurta, Ph.D

Executive Director, Translational Development and Diagnostics and leads the Myeloma Disease Group, Celgene Corporation

Laura Thrall

Consultant

Steven Tjoe, JD, MS

Associate, Goodwin Procter LLP

Jennifer K Wagner, JD, PhD

Associate Director, Bioethics Research, Assistant Professor’ Center for Translational Bioethics and Health Care Policy, Geisinger Research

Nephi Walton, MD, MS

Assistant Professor of Genomic Medicine – Geisinger Health Systems

Stephen A Williams MD PhD

Chief Medical Officer, Somalogic Inc.

Michael Yudell, PhD, MPH

Chair and Associate Professor Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University

Stephen A Williams MD PhD

Chief Medical Officer, Somalogic Inc

Giorgio Sirugo, MD, PhD

Co-Director Center Penn Medicine Biobank and adjunct Associate Professor of Medicine at the University of Pennsylvania, Perelman School of Medicine.

Michael Montalto, PhD

Vice President and Head of Translational Sciences at Bristol-Myers Squibb

Michael Rivers

Vice President and Lifecycle Leader, Digital Pathology – Roche Tissue Diagnostics

Grace Cordovano, PhD

CEO & Founder , Enlightening Results, LLC

Jeffrey Shaman, PhD.MS

Chief Scientific Officer, Coriell Life Sciences

Reto Merges

Global Head of Expanding Precision Medicine Siemens Healthineers

Kimberley Ferguson

Market Development Executive, Roche Diagnostics Information Systems

Gary Palmer, MD, JD, MBA, MPH

Chief Medical Officer, Tempus Labs, Inc.

Dwight Raum

Vice President and Chief Technology Officer of Johns Hopkins Health System and Johns Hopkins University

Ben Zeskind, PhD, MBA

Co-Founder and CEO, Immuneering

Damian P. Alagia III, MD, MS, MBA, FACS, FACOG

Franchise Medical Director for Women’s Health and Reproductive Medicine for Quest Diagnostics

Christos Hatzis, PhD

Adjunct Associate Professor of Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, Clinical Mechanisms Lead, Translational Medicine, Bristol-Myers Squibb

Susan McClure

CEO & Founder, Genome Creative

Anthony Magliocco, MD

Chair of Anatomic Pathology at the Moffitt Cancer Center and Executive Director of Esoteric Laboratory Services & CEO and President Protean Biodiagnostics

Sony Tuteja, PharmD, MS

Research Assistant Professor in the Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania.

George Lee, PhD

Digital Pathology Informatics Lead, Bristol Myers Squibb

Kelly E. Caudle, Pharm.D., Ph.D., BCPS

Clinical Pharmacogenetics Implementation Consortium (CPIC) Director at St. Jude Children’s Research Hospital & affiliate Assistant Professor at The University of Tennessee Health Science Center

Anil Parwani, MD, PhD

Vice Chair and Director, Anatomic Pathology, Department of Pathology, The Ohio State University Wexner Medical Center

Lori Anderson

Product Marketing Manager, XIFIN, Inc.

Shawn Glisson, MD

Medical Oncology/Hematology, Norton Cancer Institute

Okan Ekinci, MD, MBA

Chief Medical Officer, Roche Diagnostics Information Solutions

Julia A. Beaver, MD

Director, Division of Oncology Products 1 (DOP1), Office of Hematology and Oncology Products, FDA

Kenneth J. Pienta, M.D

The Donald S. Coffey Professor Urology, Director, Urology Research Laboratories, Professor Oncology, Pharmacology and Molecular Sciences, Chemical and Biomolecular Engineering

Peter Silvester

Senior Vice President and President, Life Sciences Solutions, Thermo Fisher Scientific

Luis Lasalvia, MD, MIB

Vice President, Global Medical Officer, Siemens Healthineers

Wendy Rubinstein, MD, PhD, FACP, FACMG

Deputy Medical Director of CancerLinQ®, a not-for-profit subsidiary of the American Society of Clinical Oncology (ASCO).

Erynn Gordon, MS, LCGC

VP of Clinical Operations, Genome Medical

Edward Abrahams, PhD

President, Personalized Medicine Coalition

Katie Johansen Taber, PhD

Director, Clinical Development, Myriad Women’s Health

John Quackenbush, PhD

Henry Pickering Walcott Professor of Computational Biology and Bioinformatics
Chair, Department of Biostatistics, Harvard University T.H. Chan School of Public Health

Jason H. Moore, PhD, FACMI

Edward Rose Professor of Informatics,Director, Institute for Biomedical Informatics,Director, Division of Informatics,
Department of Biostatistics, Epidemiology, & Informatics,Senior Associate Dean for Informatics ,The Perelman School of Medicine University of Pennsylvania

Erica Ramos, MS, LCGC

President, National Society of Genetic Counselors and Dir & Head of Clinical Business Development at Geisinger National Precision Health

David Roth, MD, PhD

Simon Flexner Professor and Chair of Pathology and Laboratory Medicine, Director, Penn Center for Precision Medicine, University of Pennsylvania Perelman School of Medicine

Amy M. Miller, PhD

President & CEO, Society for Women’s Health Research

Gary Palmer, MD

Chief Medical Officer, Tempus

Timothy A. Chan, MD, PhD

PaineWebber Chair in Cancer Genetics; Director, Immunogenomics and Precision Oncology Platform; Member, Human Oncology & Pathogenesis Program; Vice Chair, Department of Radiation Oncology; Director, Translational Oncology Division

Nicholas Dracopoli, PhD, Consultant

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Vice Chair, CTCA Department of Medical Oncology, CTCA Philadelphia

Eric B Kmiec Ph.D

Director, Gene Editing Program,Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute

Stephanie Devaney, Ph.D

Deputy Director – All of Us Research Program, National Institutes of Health.

Tara Schmidlen, MS, CGC

Clinical Investigator / Genetic Counselor – Geisinger Health System

Andrey Antov, PhD, MBA

Program Director, Maine Cancer Genomics Initiative, The Jackson Laboratory

Ilan “Lanny” Kirsch, M.D.

Senior Vice President of Translational Medicine, Adaptive Biotechnologies

David B. Nash, MD, MBA

Dean Jefferson College of Population Health, Dr. Raymond C. & Doris N. Grandon Professor of Health Policy

Selin Kurnaz, Ph.D.

CEO – Massive Bio

Yves Lussier, MD, FACMI

Associate Vice President for Health Sciences and Chief Knowledge Officer, Executive Director, Center for Biomedical Informatics and Biostatistics, University of Arizona Health Sciences

Lorenz M. Mayr, Ph.D.

Chief Technology Officer (CTO), GE Healthcare Life Sciences

Lara Mangravite, Ph.D.

President, Sage Bionetworks

Benjamin Haibe-Kains , Ph.D.

Senior Scientist, Princess Margaret Cancer Centre (PM), University Health Network, and Associate Professor in the Medical Biophysics Department of the University of Toronto

Leslie Bucheit MS, CGC

Product Manager, Digital Products, Myriad Genetics

Michael Cantor, MD, MA

Executive Director, Clinical Informatics, Regeneron Genetics Center

Philip Empey, PharmD, PhD

Associate Director, Institute of Precision Medicine, University of Pittsburgh and UPMC.

PMLS SIGN UP

Receive information about our 2020 conference speakers, schedule and registration.

REGISTER TODAY